Del Global Technologies Appoints Head for Universal Product Group.

FRANKLIN PARK, Ill. -- Del Global Technologies Corp. (OTCBB:DGTC) ("Del Global" or "the Company") today announced that Joseph F. Flies, VP of Operations for Del Medical Systems, has also been appointed to lead the newly formed Universal Product Group. The appointment was effective August 1, 2007. Mr. Flies is responsible for all sales support and product marketing for Del Medical Systems' Universal product offerings. He will continue to report directly to James A. Risher, Del Global's Chief Executive Officer.

According to Mr. Risher, "Joe's organization will provide special focus on our Universal products to support our dealers and distributors worldwide. He will continue to manage the manufacturing, engineering and customer support activities for all Del Medical Systems products." Tom Boon, Vice President of Global Sales and Marketing, will continue to lead Del Medical Systems' Global Sales and Marketing organization. "This organizational change will allow us to better balance activities between Del Medical's traditional radiographic business and our emerging digital radiographic market opportunities," according to Mr. Risher.

Del Medical Systems' Universal products are designed specifically for the veterinarian, chiropractic and medical markets. For nearly 78 years the Universal brand has been well-regarded and trusted for high quality radiographic equipment that delivers superior quality images with safety for both the patient and the operator.

The Universal branded medical products were designed for today's cost- and performance- conscious global practitioners. In the chiropractic market, the Universal analog and digital DCChoice systems are the most versatile chiropractic imaging systems in the industry. Within the veterinary market, Universal's AVChoice and DVChoice products are helping to set the industry standard. James Risher commented, "We are excited to have Joe lead the Universal business. He has a demonstrated ability in managing sales and marketing efforts in the veterinarian, chiropractic and medical markets. Through the efforts of Joe and his team, we are confident that the Universal brand will enjoy both an elevated profile and increased penetration within these markets."

Mr. Flies commented, "With our newly formed team of Product Managers, the Universal business organization will assist the extensive Universal dealer network in assembling the most cost effective solutions to meet customer needs. I believe there are significant opportunities for Universal to strengthen and expand its business platform."

Mr. Flies joined Del Medical in October 2006. From 2002-2006, Mr. Flies served as President of Summit Industries, one of the industry's manufacturers of medical, chiropractic, and veterinary x-ray equipment.

ABOUT DEL GLOBAL TECHNOLOGIES

Del Global Technologies Corp. is primarily engaged in the design, manufacture and marketing of high performance diagnostic imaging systems for medical, dental and veterinary applications through the Del Medical Systems Group. Through its U.S. based Del Medical Imaging Corp. and Milan, Italy based Villa Sistemi Medicali S.p.A. subsidiaries the Company offers a broad portfolio of general radiographic, radiographic/fluoroscopic, portable x-ray and digital radiographic systems to the global marketplace. Through its RFI subsidiary, Del Global manufactures proprietary high-voltage power conversion subsystems including electronic filters, high voltage capacitors, pulse modulators, transformers and reactors, and a variety of other products designed for industrial, medical, military and other commercial applications.

The company's web site is www.delglobal.com

Statements about future results made in this release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on current expectations and the current economic environment. Del Global cautions that these statements are not guarantees of future performance. These statements involve a number of risks and uncertainties that are difficult to predict. Actual results could differ materially from those expressed or implied in the forward-looking statements. Important assumptions and other important factors that could cause actual results to differ materially from those in the forward-looking statements are specified in the Company's filings with the Securities and Exchange Commission.